All treatments
Treatment
Cisplatino Accord Healthcare Italia 1 mg/ml concentrato per soluzione per infusione clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer (POD1UM-304)
This study looks at a new drug, retifanlimab, alongside standard chemotherapy for advanced lung cancer. It aims to see if adding retifanlimab helps people live longer and if it's safe. It's for adults with specific types of non-small cell lung cancer that has spread.
For: Metastatic nonsquamous or squamous non-small cell lung cancerCzechia · Bulgaria - AuthorisedTherapeutic confirmatory (Phase III)
Toripalimab plus chemotherapy as first-line treatment for recurrent and/or metastatic nasopharyngeal cancer: safety and activity in non-endemic population
This study is testing a new combination of treatments, including a drug called toripalimab, for a type of cancer called nasopharyngeal cancer that has come back or spread. Doctors want to see if this new treatment is safe and works well for people outside of areas where the cancer is common.
For: Recurrent Metastatic Nasopharingeal CarcinomaItaly